Top News
Chemotherapy Associated With Reduced Risk of Alzheimer Disease in CRC Survivors
Breathlessness Associated With Poor Survival in Malignant Pleural Effusions
AlloHCT Following Treatment With PD-1 mAbs Beneficial in Classic Hodgkin Lymphoma
IMiD-Free Regimen Effective in Relapsed/Refractory Multiple Myeloma
Youth With Cancer May Need Parental Help When Deciding Sperm Banking
Dasatinib, Nilotinib Effective Second-Line Therapy for Chronic Myeloid Leukemia
Acute Kidney Injury Seen With Induction Chemotherapy for Acute Myeloid Leukemia
Past Decade Has Seen Improved Outcomes in Melanoma Brain Metastasis
Upfront Low-Dose Chemo-Immunotherapy Safe, Effective for Elderly With CLL
Blinatumomab Improves Outcomes in Children With High-Risk B-ALL
Cytogenetics Predict Outcomes to Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Recommendations From FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical Trials
A workshop was convened by the US Food and Drug Administration and the American Association for Cancer Research to create recommendations for trial design and later stages of drug development in multiple myeloma. -
Socioeconomics and Cognitive Function After Childhood Brain Tumors
Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status. -
COVID-19 Vaccination and Imaging Misinterpretation
Oncologists and patients should be aware of the potential manifestations of the COVID-19 vaccination on imaging and the consequences this might have on disease assessment, treatment monitoring, and decision-making. -
Review of Barriers to Colorectal Cancer Screening in Hard-to-Reach Populations
The COVID-19 pandemic sheds new light on existing access challenges in preventive health care. -
Therapeutic Approaches to Multiple Myeloma: An Interview With Ajai Chari, MD
Ajai Chari, MD, of Mount Sinai Hospital in New York City, provides his perspective on the current state of care in multiple myeloma. -
SG-BCC 2021 Coverage
Complete coverage of the 17th St. Gallen International Breast Cancer Symposium. -
NCCN Guidelines for Multiple Myeloma Updated to Include Three Selinexor Regimens
The National Comprehensive Cancer Network’s updated Clinical Practice Guidelines in Oncology for multiple myeloma newly include 3 new selinexor-containing regimens.
More Features
NCCN Releases First Practice Guidelines for Wilms Tumor
New NCCN guidelines for Wilms tumor contain up-to-date information on screening, diagnosis, risk stratification, and treatment for this rare childhood renal cancer.
Pediatric Cancer Survivors and Diabetes: What Are the Risks?
Diabetes and metabolic syndrome represent two of the most common long-term complications in survivors of childhood cancer.
Tepotinib Now Approved to Treat NSCLC With MET Exon 14 Skipping Alterations
Xiuning Le, MD, PhD, discusses the future of tepotinib in the treatment of NSCLC. Dr Le is an author of a phase 2 study on tepotinib, a highly selective MET inhibitor.
Indications Withdrawn as FDA Evaluates Several Accelerated Approvals
To prove clinical benefit, the FDA requires manufacturers to conduct confirmatory trials, also known as a phase 4 studies.
Analysis Shows Disparities in Care Extend to Imaging Studies in Pediatric Patients
An evaluation of a large dataset sought to determine use of imaging studies in children treated in children’s hospital emergency departments.
-
Loading...
-
Loading...
